---
category: news
title: "Lantern Pharma Announces Significant Positive Preclinical Data in Pancreatic Cancer With Drug Candidate LP-184"
excerpt: "PRNewswire/ -- Lantern Pharma (NASDAQ:LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence"
publishedDateTime: 2021-07-20T11:00:00Z
originalUrl: "https://www.benzinga.com/pressreleases/21/07/n22056896/lantern-pharma-announces-significant-positive-preclinical-data-in-pancreatic-cancer-with-drug-cand"
webUrl: "https://www.benzinga.com/pressreleases/21/07/n22056896/lantern-pharma-announces-significant-positive-preclinical-data-in-pancreatic-cancer-with-drug-cand"
ampWebUrl: "https://www.benzinga.com/amp/content/22056896"
cdnAmpWebUrl: "https://www-benzinga-com.cdn.ampproject.org/c/s/www.benzinga.com/amp/content/22056896"
type: article
quality: 24
heat: 24
published: false

provider:
  name: Benzinga.com
  domain: benzinga.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://s3.amazonaws.com/wp-uploads.benzinga-premium-newsletters.prod/uploads/2021/07/15155831/Options-Trades-Feb-3-2021-5.png"
    width: 1200
    height: 600
    isCached: true

secured: "ZLB3RY3hBnX9lNcIhfirZ7q+RFEhWQmljouRpKRxPqBlcHPFO1le+EgpJxTuVbK/k4qJbsiCrkxJGLc+gYlGKjoBE+Up6X9ytxSPDvM50t8bpy1xOR9l/Aoq0YYjAv57+jPhBLV/5Zxh1EhFGHtyHWqZmCo5DbKEmsssJ42XP5NjL97lwXbTrDgmtYTZnqxkjJs2XHaWecK4ryLuE0pMpAZ/Pg/bBAR1SPfZQgSCM4UDcNvvyPfNvGqTG8/7swV7kgD7Owv/1w4IM14jj1Db15Sn1f1N8vg6cR8Q5jaS8NML8Ji12k70bOSRkJg7W1Gu6yDG+hkoDrS1SsK3NNMy+wPsLWWuRtTBc6L2Up6kghI=;rMLHmaIHBY7nGngnzRBRVg=="
---

